Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
XIANYANG, China, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement...
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice PR Newswire XIANYANG, China, April 23, 2018 XIANYANG, China, April 23, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform PR Newswire XIANYANG, China, Feb. 21, 2018 XIANYANG, China, Feb. 21, 2018 /PRNewswire/ -- Biostar...
Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification PR Newswire XIANYANG, China, Feb. 7, 2018 XIANYANG, China, Feb. 7, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Regains Compliance with NASDAQ Continued Listing Requirement PR Newswire XIANYANG, China, Dec. 4, 2017 XIANYANG, China, Dec. 4, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017 PR Newswire XIANYANG, China, Nov. 20, 2017 XIANYANG, China, Nov. 20, 2017 /PRNewswire/...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017 PR Newswire XIANYANG, China, Nov. 15, 2017 XIANYANG, China, Nov. 15, 2017 /PRNewswire/ - Biostar...
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice PR Newswire XIANYANG, China, Aug. 28, 2017 XIANYANG, China, Aug. 28, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017 PR Newswire XIANYANG, China, May 19, 2017 XIANYANG, China, May 19, 2017 /PRNewswire/ - Biostar...
Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2016 PR Newswire XIANYANG, China, April 13, 2017 XIANYANG, China, April 13, 2017 /PRNewswire/ - Biostar...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | -0.000999 | -99.9 | 0.001 | 0.001 | 1.0E-6 | 1957 | 0.00012862 | CS |
| 12 | 0 | 0 | 1.0E-6 | 0.001 | 1.0E-6 | 1354 | 0.00012584 | CS |
| 26 | 0 | 0 | 1.0E-6 | 0.001 | 1.0E-6 | 2009 | 0.00011161 | CS |
| 52 | -9.9E-5 | -99 | 0.0001 | 0.001 | 1.0E-6 | 6342 | 3.457E-5 | CS |
| 156 | -9.9E-5 | -99 | 0.0001 | 0.01 | 1.0E-6 | 3966 | 0.00011171 | CS |
| 260 | -0.067999 | -99.9985294118 | 0.068 | 0.379 | 1.0E-6 | 4650 | 0.1020829 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| HMBLHUMBL Inc (PK) | US$ 0,0009 (0,00%) | 359,72M |
| GRLFGreen Leaf Innovations Inc (PK) | US$ 0,00015 (50,00%) | 194,9M |
| AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0,00375 (-1,32%) | 188,36M |
| TSOITherapeutic Solutions International Inc (PK) | US$ 0,0002 (-33,33%) | 168,26M |
| PHILPHI Group Inc (PK) | US$ 0,00025 (-16,67%) | 129,87M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
